JP2023503379A5 - - Google Patents
Info
- Publication number
- JP2023503379A5 JP2023503379A5 JP2022532782A JP2022532782A JP2023503379A5 JP 2023503379 A5 JP2023503379 A5 JP 2023503379A5 JP 2022532782 A JP2022532782 A JP 2022532782A JP 2022532782 A JP2022532782 A JP 2022532782A JP 2023503379 A5 JP2023503379 A5 JP 2023503379A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- cancer
- treatment
- nucleosome
- extracellular free
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025093848A JP2025124845A (ja) | 2019-12-02 | 2025-06-05 | バイオマーカーとしての細胞外遊離ヌクレオソームの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962942596P | 2019-12-02 | 2019-12-02 | |
| US62/942,596 | 2019-12-02 | ||
| US202063088408P | 2020-10-06 | 2020-10-06 | |
| US63/088,408 | 2020-10-06 | ||
| PCT/EP2020/084328 WO2021110776A1 (en) | 2019-12-02 | 2020-12-02 | Use of cell free nucleosomes as biomarkers |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025093848A Division JP2025124845A (ja) | 2019-12-02 | 2025-06-05 | バイオマーカーとしての細胞外遊離ヌクレオソームの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023503379A JP2023503379A (ja) | 2023-01-27 |
| JP2023503379A5 true JP2023503379A5 (enExample) | 2023-12-11 |
| JP7693670B2 JP7693670B2 (ja) | 2025-06-17 |
Family
ID=73698838
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532782A Active JP7693670B2 (ja) | 2019-12-02 | 2020-12-02 | バイオマーカーとしての細胞外遊離ヌクレオソームの使用 |
| JP2025093848A Pending JP2025124845A (ja) | 2019-12-02 | 2025-06-05 | バイオマーカーとしての細胞外遊離ヌクレオソームの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025093848A Pending JP2025124845A (ja) | 2019-12-02 | 2025-06-05 | バイオマーカーとしての細胞外遊離ヌクレオソームの使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20230003735A1 (enExample) |
| EP (2) | EP4435431A3 (enExample) |
| JP (2) | JP7693670B2 (enExample) |
| KR (1) | KR102930652B1 (enExample) |
| CN (1) | CN114829939B (enExample) |
| AU (1) | AU2020395504A1 (enExample) |
| BR (1) | BR112022010774A2 (enExample) |
| CA (1) | CA3163181A1 (enExample) |
| ES (1) | ES2988371T3 (enExample) |
| IL (1) | IL293342B2 (enExample) |
| MX (1) | MX2022006655A (enExample) |
| PL (1) | PL4070111T3 (enExample) |
| TW (1) | TWI902730B (enExample) |
| WO (1) | WO2021110776A1 (enExample) |
| ZA (1) | ZA202205916B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4155401A1 (en) * | 2012-03-02 | 2023-03-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2015138774A1 (en) | 2014-03-13 | 2015-09-17 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| WO2023073179A1 (en) | 2021-10-29 | 2023-05-04 | Belgian Volition Srl | Homogeneous immunoassay method |
| GB202117799D0 (en) | 2021-12-09 | 2022-01-26 | Belgian Volition Srl | Method for the detection of blood cancer |
| US20250197944A1 (en) | 2022-03-11 | 2025-06-19 | Belgian Volition Srl | Differential diagnosis method |
| EP4577833A1 (en) | 2022-08-25 | 2025-07-02 | Belgian Volition SRL | Method for measuring cell free chromatin |
| EP4639173A1 (en) * | 2022-12-19 | 2025-10-29 | Belgian Volition SRL | Calibration |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0319376D0 (en) | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| GB0413732D0 (en) * | 2004-06-13 | 2004-07-21 | Chroma Therapeutics Ltd | Histone modification |
| ATE534908T1 (de) * | 2009-08-03 | 2011-12-15 | Universitaetsklinikum Freiburg | Verfahren und verbindungen zur diagnose und behandlung von krebs |
| GB201115095D0 (en) | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| GB201115099D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| JP6263474B2 (ja) | 2011-12-07 | 2018-01-17 | シンガポール ボリション ピーティーイー リミテッド | ヌクレオソームアダクト検出法 |
| EP4155401A1 (en) * | 2012-03-02 | 2023-03-29 | Sequenom, Inc. | Methods and processes for non-invasive assessment of genetic variations |
| US9388213B2 (en) * | 2012-09-10 | 2016-07-12 | The Rockefeller University | Polycomb repressive complex 2 (PRC2) inhibitors and uses thereof |
| SG11201702978VA (en) | 2014-10-29 | 2017-05-30 | Belgian Volition Sprl | Method for the enrichment of circulating tumor dna |
| GB201511542D0 (en) * | 2015-07-01 | 2015-08-12 | Singapore Volition Pte Ltd | Use of cell free nucleosomes as biomarkers |
| GB201511512D0 (en) * | 2015-07-01 | 2015-08-12 | Singapore Volition Pte Ltd | Use of cell-free nucleosomes as biomarkers |
| GB201518665D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| GB201518674D0 (en) | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for detecting nuleosomes containing histone modifications and variants |
| CN111918971B (zh) * | 2018-03-01 | 2024-09-03 | 埃皮塞弗公司 | 利用化学确定的重组核小体定量核小体修饰 |
-
2020
- 2020-12-02 US US17/781,652 patent/US20230003735A1/en active Pending
- 2020-12-02 WO PCT/EP2020/084328 patent/WO2021110776A1/en not_active Ceased
- 2020-12-02 CN CN202080083887.9A patent/CN114829939B/zh active Active
- 2020-12-02 ES ES20819704T patent/ES2988371T3/es active Active
- 2020-12-02 JP JP2022532782A patent/JP7693670B2/ja active Active
- 2020-12-02 KR KR1020227022609A patent/KR102930652B1/ko active Active
- 2020-12-02 MX MX2022006655A patent/MX2022006655A/es unknown
- 2020-12-02 IL IL293342A patent/IL293342B2/en unknown
- 2020-12-02 PL PL20819704.6T patent/PL4070111T3/pl unknown
- 2020-12-02 EP EP24193398.5A patent/EP4435431A3/en active Pending
- 2020-12-02 EP EP20819704.6A patent/EP4070111B1/en active Active
- 2020-12-02 TW TW109142306A patent/TWI902730B/zh active
- 2020-12-02 AU AU2020395504A patent/AU2020395504A1/en active Pending
- 2020-12-02 CA CA3163181A patent/CA3163181A1/en active Pending
- 2020-12-02 BR BR112022010774A patent/BR112022010774A2/pt unknown
-
2022
- 2022-05-27 ZA ZA2022/05916A patent/ZA202205916B/en unknown
-
2025
- 2025-06-05 JP JP2025093848A patent/JP2025124845A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bivona et al. | Biomarkers for prognosis and treatment response in COVID-19 patients | |
| Sayah et al. | Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19 | |
| Mardi et al. | Mean cell volume of neutrophils and monocytes compared with C‐reactive protein, interleukin‐6 and white blood cell count for prediction of sepsis and nonsystemic bacterial infections | |
| JP6595984B2 (ja) | 腎機能に関連付けられるバイオマーカーおよびそれを使用する方法 | |
| Teeuw et al. | Periodontitis as a possible early sign of diabetes mellitus | |
| Fu et al. | Comparison of non-invasive biomarkers faecal BAFF, calprotectin and FOBT in discriminating IBS from IBD and evaluation of intestinal inflammation | |
| Yamamoto et al. | Consecutive monitoring of faecal calprotectin during mesalazine suppository therapy for active rectal inflammation in ulcerative colitis | |
| JP2018529931A5 (enExample) | ||
| EP2222220A1 (en) | Trimethylamine compounds as risk predictors of cardiovascular disease | |
| Tun et al. | Specificity of cardiac troponin I and creatine kinase-MB isoenzyme in asymptomatic long-term hemodialysis patients and effect of hemodialysis on these cardiac markers | |
| Outinen et al. | Plasma cell-free DNA levels are elevated in acute Puumala hantavirus infection | |
| Ye et al. | Serum platelet factor 4 is a reliable activity parameter in adult patients with inflammatory bowel disease: A pilot study | |
| JP2023539867A5 (enExample) | ||
| WO2010036901A1 (en) | Methods and kits for diagnosing obstructive sleep apnea | |
| Eastwood et al. | Impact of kidney function on cardiovascular risk and mortality: a comparison of South Asian and European cohorts | |
| Cheng et al. | Variation of red blood cell parameters in Behcet’s disease: association with disease severity and vascular involvement | |
| JP2019168319A (ja) | 小児がん検査用尿中代謝物マーカー | |
| Keskin et al. | Prognostic value of preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios, and multiphasic renal tomography findings in histological subtypes of renal cell carcinoma | |
| JP5246709B2 (ja) | 自己免疫疾患検査用バイオマーカー及び検査方法 | |
| Joen et al. | Diagnostic value of procalcitonin and CRP in critically ill patients admitted with suspected sepsis | |
| Şimşek-Onat et al. | Neutrophil-to-lymphocyte ratio: an easy marker for the diagnosis and monitoring of inflammatory bowel disease in children | |
| Späth et al. | Immune marker changes and risk of multiple myeloma: a nested case-control study using repeated pre-diagnostic blood samples | |
| Alevrakis et al. | Strong ion gap and anion gap corrected for albumin and lactate in patients with sepsis in the intensive care unit | |
| JP7226732B2 (ja) | 尿中腫瘍マーカーによるがん検出方法、キット及び装置 | |
| Peeters et al. | Beyond BMI: how to capture influences from body composition in health surveys |